Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
about
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Randomised Phase 2 study of ma ...... ed non-small cell lung cancer.
@en
Randomised Phase 2 study of maintenance linsitinib
@nl
type
label
Randomised Phase 2 study of ma ...... ed non-small cell lung cancer.
@en
Randomised Phase 2 study of maintenance linsitinib
@nl
prefLabel
Randomised Phase 2 study of ma ...... ed non-small cell lung cancer.
@en
Randomised Phase 2 study of maintenance linsitinib
@nl
P2093
P2860
P356
P1476
Randomised Phase 2 study of ma ...... ed non-small cell lung cancer.
@en
P2093
Debbie Whitcomb
Jan M VanTornout
Jihong Chen
Joo-Hang Kim
Jörg Mezger
Keunchil Park
Michael Thomas
Samreen Ahmed
Srinivasu Poondru
P2860
P2888
P304
P356
10.1038/BJC.2017.226
P407
P577
2017-08-03T00:00:00Z